Risk factors for vaginal vault prolapse surgery in postmenopausal hysterectomized women

Menopause

Volumn 15, Issue 6, 2008, Pages 1115-1119

  Forsgren, Catharina ^a   Zetterstram, Jan ^a   Lopez, Annika ^a   Altman, Daniel ^a,b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Hysterectomy; Menopause.; Risk factor; Vaginal vault prolapse

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGE; ARTICLE; BIRTH WEIGHT; BODY MASS; CASE CONTROL STUDY; CESAREAN SECTION; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HORMONAL THERAPY; HUMAN; HYSTERECTOMY; INSTRUMENTAL DELIVERY; LACERATION; LAPAROSCOPIC SURGERY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATERNAL AGE; MENOPAUSE; MULTIPARA; MULTIVARIATE ANALYSIS; NULLIPARA; PARITY; PELVIC ORGAN PROLAPSE; PHYSICAL ACTIVITY; POSTMENOPAUSE; POSTOPERATIVE COMPLICATION; QUESTIONNAIRE; RISK FACTOR; SMOKING; VAGINAL DELIVERY; VAGINAL HYSTERECTOMY; VAGINAL INJURY; VAGINAL VAULT PROLAPSE; AGED; HEALTH SURVEY; HORMONE SUBSTITUTION; MIDDLE AGED; PELVIS FLOOR; RISK; STRESS INCONTINENCE; UTERUS PROLAPSE;

AGE FACTORS; AGED; CASE-CONTROL STUDIES; FEMALE; HEALTH SURVEYS; HORMONE REPLACEMENT THERAPY; HUMANS; HYSTERECTOMY; MIDDLE AGED; ODDS RATIO; PELVIC FLOOR; POSTMENOPAUSE; RISK FACTORS; URINARY INCONTINENCE, STRESS; UTERINE PROLAPSE;

EID: 63349103714     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e31817062a5     Document Type: Article

References (24)

1. Lepine LA, Hillis SD, Marchbanks PA, et al. Hysterectomy surveillance-United States 1980-1993. MMWR CDC Surveill Summ 1997;46:1-15.
2. Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 2002;99:229-234.
3. Whiteman MK, Hillis SD, Jamieson DJ, et al. Inpatient hysterectomy surveillance in the United States, 2000-2004. Am J Obstet Gynecol 2008;198:e1-e7.
4. Samuelsson EC, Arne Victor FT, Tibblin G, Svardsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol 1999;180:299-305.
5. Symmonds RE, Williams TJ, Lee RA, Webb MJ. Posthysterectomy enterocele and vaginal vault prolapse. Am J Obstet Gynecol 1981;140:852-859.
6. Marcionni M, Bracco GL, Checcucci V, et al. True incidence of vaginal vault prolapse. Thirteen years of experience. Reprod J Med 1999;44:679-684.
7. Marana HR, Andrade JM, Marana RR, Matheus de Sala M, Philbert PM, Rodrigues R. Vaginal hysterectomy for correcting genital prolapse. Long-term evaluation. J Reprod Med 1999;44:529-534.
8. Maher C, Baessler K, Glazener C, Adams E, Hagen S. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev 2004;18:CD004014.
9. Altman D, Granath F, Cnattingius S, Falconer C. Hysterectomy and risk for stress-urinary-incontinence surgery: nationwide cohort study. Lancet 2007;370:1494-1499.
10. Nilsson A, Spetz C, Carsjö K, Nightingale R, Smedby B. Reliability of the hospital registry. The diagnostic data are better than their reputation. Läkartidningen (Swedish Med J) 1994;91:603-605.
11. Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 1997;89:501-506.
12. Dällenbach P, Kaelin-Gambirasio I, Dubuisson J-B, Boulvain M. Risk factors for pelvic organ prolapse repair after hysterectomy. Obstet Gynecol 2007;110:625-632.
13. Falconer C, Ekman G, Malmstrom A, Ulmsten U. Decreased collagen synthesis in stress-incontinent women. Obstet Gynecol 1994;84:583-586.
14. Norton PA, Baker JE, Sharp HC, Warenski JC. Genitourinary prolapse and joint hypermobility in women. Obstet Gynecol 1995;85:225-228.
15. Kjølhede P, Rydén G, Norén B. Prediction of genital prolapse after Burch colposuspension. Acta Obstet Gynecol Scand 1996;75:849-854.
16. Morrill M, Lukacz ES, Lawrence JM, Nager CW, Contreras R, Luber KM. Seeking healthcare for pelvic floor disorders: a population-based study. Am J Obstet Gynecol 2007;86:e1-e6.
17. Hendrix S, Cochrane B, Nygaard I, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005;293:935-948.
18. Jack SG, Ganka N, Vilain E, Raz S, Rodríguez LV. Familial transmission of genitovaginal prolapse. Int Urogynecol J 2006;17:498-501.
19. Makinen J, Soderstrom KO, Kiilholma P, Hirvonen T. Histological changes in the vaginal connective tissue of patients with and without uterine prolapse. Arch Gynecol 1986;239:17-20.
20. Mant J, Painter R, Vessey M. Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study. Br J Obstet Gynaecol 1997;104:579-585.
21. MacLennan AH, Taylor AW, Wilson DH, Wilson D. The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. Br J Obstet Gynaecol 2000;107:1460-1470.
22. Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002;186:1160-1166.
23. Tegerstedt G, Miedel A, Maehle-Schmidt M, Nyrén O, Hammarström M. Obstetric risk factors for symptomatic prolapse: a population-based approach. Am J Obstet Gynecol 2006;194:75-81.
24. Rortveit G, Brown JS, Thom DH, Van den Eeden S, Creasman JM, Subak LL. Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gynecol 2007;109:1396-1403.